Market capitalization | $539.85m |
Enterprise Value | $537.40m |
P/E (TTM) P/E ratio | negative |
EV/FCF (TTM) EV/FCF | negative |
P/B ratio (TTM) P/B ratio | 0.59 |
Dividend yield | 20.27% |
Last dividend (FY23) | $1.20 |
Short interest | 4.12% |
As a Free StocksGuide user, you can view scores for all 6,897 stocks worldwide.
+/-
%
|
|||
Revenue | - - |
-
|
|
Gross Profit | - - |
-
|
|
EBITDA | - - |
-
|
EBIT (Operating Income) EBIT | - - |
-
|
Net Profit | - - |
-
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
9 Meters Biopharma, Inc. is a clinical-stage biopharmaceutical company. It focuses on developing novel medicines for autoimmune inflammatory disease. The company is founded by Jay P. Madan and Kendyle Woodard in 2012 and is headquartered in Raleigh, NC.
Head office | United States |
CEO | Jason Serrano |
Founded | 2003 |
Website | www.nymtrust.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.